Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond

dc.contributor.authorKatsios, C.en
dc.contributor.authorZiogas, D. E.en
dc.contributor.authorRoukos, D. H.en
dc.date.accessioned2015-11-24T19:29:47Z
dc.date.available2015-11-24T19:29:47Z
dc.identifier.issn1747-4132-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22996
dc.rightsDefault Licence-
dc.subjectAntibodies, Monoclonal/*therapeutic useen
dc.subjectAntineoplastic Agents/*therapeutic useen
dc.subjectColorectal Neoplasms/*drug therapy/genetics/mortality/pathologyen
dc.subjectGenetic Testingen
dc.subjectGenotypeen
dc.subjectHumansen
dc.subjectMolecular Targeted Therapyen
dc.subject*Mutationen
dc.subjectPatient Selectionen
dc.subjectPhenotypeen
dc.subjectPhosphatidylinositol 3-Kinases/*geneticsen
dc.subjectProto-Oncogene Proteins/*geneticsen
dc.subjectProto-Oncogene Proteins B-raf/*geneticsen
dc.subjectTreatment Outcomeen
dc.subjectras Proteins/*geneticsen
dc.titleColorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyonden
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1586/egh.10.62-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20932136-
heal.identifier.secondaryhttp://www.expert-reviews.com/doi/pdfplus/10.1586/egh.10.62-
heal.journalNameExpert Rev Gastroenterol Hepatolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: